COLPALNSEColgate Palmolive (India) Limited· Personal CareMediumNeutral
Announced Fri, 22 May · 17:26 IST

Colgate Palmolive (India) Limited has informed the Exchange about Investor Presentation

Investor Communications View source PDF

COLPAL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-3.2%1-day move
₹2158.90
prior close
₹2185.70
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.7-1.0-1.5-4.5-3.2-3.1-4.4-7.7-7.6-7.1-2.8-7.8-1.1
Up moveDown movePending
AI summary

Colgate Palmolive India reported Q4 FY26 Net Sales of ₹1,583 crore (+9% YoY) with NPAT of ₹353 crore (+9.2% YoY, excluding one-offs and GST impact). Full Year FY26 saw flat revenue at ₹5,984 crore with NPAT of ₹1,325 crore (-1.8% YoY), though the company highlighted sharp recovery in H2'26 with 5.2% NS growth. Gross margins remained strong at 69.6% in Q4 and 69.3% for FY26, with EBITDA margins at 32.2% and 31.2% respectively. The presentation emphasized margin resilience and superiority versus peers, driven by strategic pricing, cost savings initiatives, and premiumization. Brand investments increased 10% YoY in Q4 to ₹199 crore and 7% for FY26 to ₹819 crore, while the company maintained consistent dividend payouts and strong cash generation.

Likely market impact

Strong Q4 recovery and resilient margin profile (EBITDA 32.2%) with ongoing premiumization investments signal business health, though full-year flat topline growth remains a watchpoint. The company's maintained gross margins above 69% demonstrates pricing power and cost efficiency.